| 1 |
33622325 | Olodaterol exerts anti-inflammatory effects on COPD airway epithelial cells. | 2021 Feb 23 |
3 |
| 2 |
31425937 | Ultra-LABAs for the treatment of asthma. | 2019 Sep |
1 |
| 3 |
30311516 | Olodaterol for the treatment of chronic obstructive pulmonary disease: a narrative review. | 2018 Oct |
1 |
| 4 |
28810065 | Olodaterol shows anti-fibrotic efficacy in in vitro and in vivo models of pulmonary fibrosis. | 2017 Nov |
1 |
| 5 |
26348533 | Investigating pulmonary and systemic pharmacokinetics of inhaled olodaterol in healthy volunteers using a population pharmacokinetic approach. | 2016 Mar |
1 |
| 6 |
25773742 | Olodaterol: a review of its use in chronic obstructive pulmonary disease. | 2015 Apr |
1 |
| 7 |
25781609 | Olodaterol attenuates citric acid-induced cough in naïve and ovalbumin-sensitized and challenged guinea pigs. | 2015 |
2 |
| 8 |
25824824 | The long-acting β2 -adrenoceptor agonist olodaterol attenuates pulmonary inflammation. | 2015 Jul |
3 |
| 9 |
26676161 | Differential pharmacology and clinical utility of long-acting bronchodilators in COPD - focus on olodaterol. | 2015 |
1 |
| 10 |
24705868 | Dual regulation of β2-adrenoceptor messenger RNA expression in human lung fibroblasts by β2-cAMP signaling; delayed upregulated inhibitors oppose a rapid in onset, direct stimulation of gene expression. | 2014 Jul |
1 |
| 11 |
24158691 | Olodaterol: first global approval. | 2013 Nov |
1 |
| 12 |
22483689 | Endothelin-1 enhances β₂-adrenoceptor gene transcription in human lung fibroblasts. | 2012 Oct 15 |
2 |
| 13 |
22796455 | β₂-adrenoceptors and muscarinic receptors mediate opposing effects on endothelin-1 expression in human lung fibroblasts. | 2012 Sep 15 |
1 |
| 14 |
21357659 | Functional and biochemical rationales for the 24-hour-long duration of action of olodaterol. | 2011 Jun |
2 |
| 15 |
21839850 | 24-hour bronchodilation following a single dose of the novel β(2)-agonist olodaterol in COPD. | 2011 Dec |
2 |
| 16 |
20096576 | Discovery of olodaterol, a novel inhaled beta2-adrenoceptor agonist with a 24 h bronchodilatory efficacy. | 2010 Feb 15 |
1 |
| 17 |
20371707 | Pharmacological characterization of olodaterol, a novel inhaled beta2-adrenoceptor agonist exerting a 24-hour-long duration of action in preclinical models. | 2010 Jul |
1 |